Amplion

Amplion Inc. operates BiomarkerBase, a comprehensive database that focuses on clinical biomarkers and their molecular counterparts tested in clinical settings. This database aids users in navigating the clinical biomarker landscape and supports strategic decisions related to the commercial application of molecular biomarkers. The company offers a biomarker engine, an end-to-end workflow tool designed to manage both structured and unstructured data, which includes capabilities for data filtering, annotation, and learning from these annotations. Additionally, Amplion provides an alert service that notifies users via email when specific biomarker targets or diseases are associated with new tests, drug labels, or clinical trials. Founded in 2013 and located in Bend, Oregon, Amplion leverages machine learning to enhance insights within the biomedical sector and identify business opportunities in drug research and development.